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Received May 9, 2016; accepted July 30, 2016AbstractBackground: Metabolic syndrome has been highlighted as a risk factor for several gastrointestinal diseases, including gastroesophageal reflux
disease and Barrett’s esophagus (BE). The aim of this study was to investigate the association of metabolic syndrome with erosive esophagitis
(EE) and BE.
Methods: Data were retrospectively collected from patients who visited the Medical Screening Center at Taichung Veterans General Hospital,
Taichung, Taiwan from January 2006 to December 2009. All patients underwent an open-access transoral upper gastrointestinal endoscopy, and
serum laboratory data were collected. The exclusion criteria included prior gastric surgery, or presence of esophageal varices or peptic ulcers.
These patients were assigned to groups according to their endoscopic findings as follows: (1) normal group; (2) EE group; and (3) BE group.
Metabolic syndrome was diagnosed based on the International Diabetes Federation criteria.
Results: Therewere 560/6499 (8.6%) patients, 214/1118 (9.6%) patients, and 19/95 (20%) patients withmetabolic syndrome in the normal, EE, and
BE groups, respectively. There was a significantly higher percentage of cases with hypertriglyceridemia in the EE group (67%) compared with the
other groups. The BE group had significantly higher rates of central obesity (33%) and hypertension (29.5%) compared with rates in the normal and
EE groups. After adjusting for confounders, the positive association with metabolic syndrome still existed in both the EE group (adjusted odds
ratio¼ 2.43; 95% confidence interval¼ 1.02e3.44) and the BE group (adjusted odds ratio¼ 2.82; 95% confidence interval¼ 2.05e3.88).
Conclusion: Our research indicated that in fact there is a greater risk of concurrent metabolic syndrome in patients with EE or BE.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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terol, fasting glycemia, and blood pressure.1 Metabolic syn-
drome has become a major public health challenge worldwide.
In Taiwan, the prevalence rate of metabolic syndrome is
20%.2,3 Metabolic syndrome has been highlighted as a risk
factor for some gastrointestinal diseases, including gastro-
esophageal reflux disease (GERD) and Barrett’s esophagus
(BE).4 Patients with GERD may present with a broad range of
troublesome symptoms that can damage quality of life, and BE
is associated with the presence of premalignant lesions that
lead to adenocarcinoma of the esophagus and gastroesopha-
geal junction. BE is defined by the pathological phenotype ofsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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investigate the association between metabolic syndrome and
erosive esophagitis (EE) or BE in a Chinese population.
2. Methods
Data from patients who visited the Medical Screening
Center at Taichung Veterans General Hospital, Taichung,
Taiwan were retrospectively collected from January 2006 to
December 2009. The general data of enrolled patients were
recorded, including age, gender, body weight, body mass
index (BMI), waist circumference, blood pressure, fasting
glucose, TG, and HDL. All patients underwent an open-access
transoral upper gastrointestinal endoscopy, and the findings of
each case were collected. The exclusion criteria included prior
gastric surgery, or presence of esophageal varices or peptic
ulcers.
All endoscopic procedures were performed by experienced
endoscopists. The patients were assigned to groups according
to whether upper gastrointestinal endoscopy showed normal
appearance (normal group), EE, or BE. BE was defined as
endoscopically suspected esophageal metaplasia with
specialized intestinal metaplasia documented by biopsy
pathology.
Metabolic syndrome was diagnosed based on the 2005 In-
ternational Diabetes Federation criteria with ethnicity-specific
values: central obesity (waist circumference  90 cm for men
and  80 cm for women), combined with any two of the
following four conditions: (1) TG levels  150 mg/dL); (2)
HDL levels < 40 mg/dL for men and < 50 mg/dL for women;
(3) fasting glucose levels > 100 mg/dL); and (4) systolic blood
pressure  130 mmHg or diastolic blood pressure 
85 mmHg.
Data are expressed as standard deviation of the mean for
each of the measured parameters. Gender, positive ratio of
metabolic syndrome and its associated components are
expressed as a percentage of the total patient number. Statis-
tical comparisons were made using Pearson’s c2 test to
compare the effects of gender and positive ratio of metabolic
syndrome and individual components. Independent t test was
used to analyze age, body weight, and BMI. A p value < 0.05
was considered statistically significant. Multivariate Cox’s
regression was used to examine the strength of associationTable 1
The characteristics of enrolled patients.
Normal (n¼ 6499, 84.3%) EE (n¼ 111
Mean± SD n % Mean± SD
Age 52.34± 11.81 52.48± 12.17
BW 64.30± 11.70 69.52± 11.58
BMI 24.07± 3.39 25.10± 3.35
Gender
M 3447 (53.0)
F 3052 (47.0)
* p values were analyzed with Pearson’s c2 test; independent t test.
BE¼Barrett’s esophagus; BMI¼ body mass index; BW¼ body weigh; EE¼ eros
derivation.between metabolic syndrome and EE or BE, and odds ratios
(OR) with 95% confidence interval (CI) were reported.
3. Results
Among all 7712 enrolled patients, there were 6499
(84.3%), 1118 (14.5%), and 95 (1.2%) in the normal, EE, and
BE groups, respectively. The characteristics of these patients
are summarized in Table 1. The mean ages of the three groups
were similar. The patients in the EE group (69.52 kg, 25.1 kg/
m2) had significantly higher body weight and BMI than pa-
tients in the normal group (64.3 kg, 24.07 kg/m2) and BE
group (65.38 kg, 23.92 kg/m2). The male predominance was
significant in the EE (80.2%) and BE (64.2%) groups. The
propotion of patients with EE L.A. Grades A/B and C/D were
81.7% (913 cases) and 18.3% (205 cases), respectively.
Among all of the enrolled cases, there were 686 individuals
(8.9%) with metabolic syndrome; the associations of normal
cases, EE, and BE with metabolic syndrome are displayed in
Table 2. There were 560 (8.6%) cases, 214 (9.6%) cases, and
19 (20%) cases with metabolic syndrome in the normal, EE
and BE groups, respectively. The difference was significant
( p¼ 0.001). Among individuals in the BE group, there were
significantly higher percentages of abnormal waist circum-
ference (33%) and hypertension (29.5%) compared with those
of the other groups. The EE group had the highest prevalence
of hypertriglyceridemia (61.7%), which was statistically
significant.
The strength of the association between each group and
metabolic syndrome is disclosed in Table 3. After adjustment
for measured potential confounders, including age, sex, and
body weight, a significant positive association with metabolic
syndrome was found in the EE group (adjusted OR¼ 2.43;
95% CI¼ 1.02e3.44) and BE group (adjusted OR¼ 2.82;
95% CI¼ 2.05e3.88).
4. Discussion
Among all 7712 enrolled cases in our study, the rates of EE
and BE were 14.5% and 1.2%, respectively. According to the
results of a large series reported in an epidemiological study,
the frequency of EE in Western countries was in the upper
range, with rates between 7% and 22%; but in Eastern8, 14.5%) BE (n¼ 95, 1.2%) p
n % Mean± SD n %
53.00± 12.87 0.649
65.38± 12.22 0.001
23.92± 3.20 0.001
897 (80.2) 61 (64.2) 0.001
221 (19.8) 34 (35.8)
ive esophagitis; F¼ female; M¼male; n¼ number of patients; SD¼ standard
Table 2
The association of cases with normal, erosive esophagitis or Barrett's esophagus with metabolic syndrome.a
Normal (n¼ 6499, 84.3%) EE (n¼ 1118, 14.5%) BE (n¼ 95, 1.2%) p*
n % n % n %
Metabolic syndrome 560 (8.6) 107 (9.6) 19 (20.0) 0.001
Waist 1042 (16.0) 170 (15.2) 31 (33.0) 0.003
TG 3042 (46.8) 690 (61.7) 32 (33.7) 0.001
HDL 864 (13.3) 112 (10.1) 16 (16.8) 0.086
Glucose 1576 (24.2) 346 (30.9) 21 (21.8) 0.335
BP 158 (2.4) 22 (2.0) 18 (29.5) 0.001
* All p values were analyzed with Pearson’s c2 test.
BE¼Barrett’s esophagus; BP¼ blood pressure; EE¼ erosive esophagitis; HDL¼ high-density lipoprotein; M¼mean; n¼ number of patients; TG¼ triglyceride.
a Positive for waist means circumference  90 cm for men and  80 cm for women; positive for TG means TG levels  150 mg/dL; positive for HDL means
HDL levels < 40 mg/dL for men and < 50 mg/dL for women; positive for glucose means fasting glucose levels > 100 mg/dL; positive for BP means systolic BP 
130 mmHg or diastolic BP  85 mmHg.
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frequency of EE. Furthermore, studies on the prevalence of BE
in Asians are scarce. One previous report in Taiwan found nine
(2%) cases diagnosed with BE among 464 patients underwent
endoscopy for a variety of upper gastrointestinal symptoms.6
However, with changes in lifestyle, dietary habits, and body
mass, an increasing trend of GERD has been reported,7 which
may potentially increase the prevalence rates of BE in the
future.8
With respect to EE, a significant positive association with
male gender and increased BMI were reported.9 Obesity is
associated with increased intra-abdominal pressure, impaired
gastric emptying, decreased lower esophageal sphincter pres-
sure, and increased frequency of transient sphincter relaxation,
thus leading to increased esophageal acid exposure and
esophagitis.10 A retrospective caseecontrol study in Taiwan
found that more patients with metabolic syndrome had EE
compared with those without metabolic syndrome (OR¼ 1.76;
95% CI¼ 1.27e2.44).11 A cross-sectional study of 7078
South Korean individuals undergoing upper endoscopy during
a health check-up reported metabolic syndrome was associated
with EE (OR¼ 1.42; 95% CI¼ 1.26e1.60).12 Another cross-
sectional study in South Korea involving 1679 cases with EE
and 3358 control cases, also found a positive association be-
tween EE and metabolic syndrome (OR¼ 1.25; 95%
CI¼ 1.04e1.49).13 Regarding BE, obesity was associated
with a 2.5-fold increase in the risk of BE.14
In our study, the percentages of patients with metabolic
syndrome were 9.6% and 20% in the EE and BE groups,Table 3
The strength of the association between cases with normal, erosive esophagitis
or Barrett's esophagitis and metabolic syndrome.
Endoscopic findings OR (95% CI) ORa (95% CI)
None 1.0 (reference) 1.0 (reference)
EE 2.21 (0.94e3.82) 2.43 (1.02e3.44)
BE 2.70 (1.97e3.71) 2.82 (2.05e3.88)
Analyzed with multivariate Cox’s regression
BE¼Barrett’s esophagus; CI¼ confidence interval; EE¼ erosive esophagitis;
OR¼ odds ratio.
a Adjusted for age, sex, and body weightrespectively, which were significantly higher than that found in
the normal group. The strength of the association between
metabolic syndrome and both EE and BE was strongly posi-
tive. Our result provides evidence that up to 20% of patients
with BE could have concurrent metabolic syndrome, but the
prevalence rate was lower in EE patients (9.6%).
Among the individual components of metabolic syndrome,
previous studies found central obesity and hyper-
triglyceridemia were significantly associated with EE.11,12 Our
results indicated that hypertriglyceridemia, but not waist
circumference, was significantly associated with EE. The
reason for the high prevalence of elevated serum TG levels in
patients with EE might reflect lifestyle factors including
consumption of high-fat meals, which could delay gastric
emptying, thus leading to EE.11 Another Japanese study re-
ported that BMI and triglyceride levels were predictors of an
increased prevalence of EE, but central obesity did not show a
similar prevalence after adjusting for confounders.15
By contrast, the enrolled cases with BE in our study had
significantly higher rates of central obesity and hypertension.
Interestingly, body weight and BMI were significantly higher
in individuals with EE, but not in cases with BE. One previous
retrospective caseecontrol study showed that visceral obesity,
measured by computed tomography scan, was an even stron-
ger independent risk factor for BE than BMI.16 These findings
imply that central obesity plays a major a role in the risks of
BE, but only a partial role in EE. For example, male gender,
hiatal hernia, Helicobacter pylori infection, smoking, and
alcohol consumption were also reported as risk factors of
EE.17,18
There were several limitations in this study. First, potential
risk factors for EE and BE, such as H. pylori, hiatal hernia,
lifestyle, and dietary habits, were not assessed. Second, we did
not determine if patients were on medications to control blood
pressure, lipids, or glucose, which might have underestimated
the ratio of metabolic syndrome. In addition, those patients on
medication with anti-acid secretory agents were not adjusted.
Third, our study was hospital based and all participants were
enrolled from a self-paid health check-up. Selection bias might
have existed due to the relatively high socioeconomic status of
these individuals. Finally, our study was not intended to clarify
18 S.-W. Lee et al. / Journal of the Chinese Medical Association 80 (2017) 15e18the prevalence of EE among metabolic syndrome patients
because GERD is considered to be a risk factor for metabolic
syndrome. However, further community-based research with
analysis of more variables is needed.
In conclusion, our study found that patients with EE as well
as those with BE had a higher prevalence rate of metabolic
syndrome. A large proportion of cases with EE had hyper-
triglyceridemia, and there was a greater prevalence of central
obesity and hypertension in patients with BE.
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